(Q43464162)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

relapsing-remitting multiple sclerosis

24 February 2020

main subject

multiple sclerosis

0 references

0 references

author

Filippo Martinelli Boneschi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Federica Esposito

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

M Romeo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

M Rodegher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

V Martinelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

G Comi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

San Raffaele Multiple Sclerosis Clinical Group

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

1 reference

20 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neurology

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

1060-1067

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

24 February 2020

cites work

1 reference

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

21 January 2018

1 reference

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

Multiple sclerosis: current treatment algorithms.

21 January 2018

1 reference

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group

21 January 2018

1 reference

A post-marketing study on immunomodulating treatments for relapsing-remitting multiple sclerosis in Lombardia: preliminary results

21 January 2018

1 reference

Defining interferon beta response status in multiple sclerosis patients.

21 January 2018

1 reference

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis

21 January 2018

1 reference

Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients

21 January 2018

1 reference

Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

21 January 2018

1 reference

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ENE.12119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23425504%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference